Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Medicine and Science in Sports and Exercise|July 22, 2022
Feasibility, Safety, and Preliminary Efficacy of Very Low-Volume Interval Training in Advanced Cancer PatientsDejan Reljic, Hans J Herrmann, Benedikt Jakobs, et al.
Cancers|February 3, 2021
Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic CellsAnn-Katrin Menzner, Tanja Rottmar, Simon Voelkl, et al.
Plos One|August 23, 2012
Comparative expression profiling of distinct T cell subsets undergoing oxidative stressRudolf Lichtenfels, Dimitrios Mougiakakos, C Christian Johansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2024
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndromeSimon Faissner, Jeremias Motte, Melissa Sgodzai, et al.
Oncotarget|July 14, 2016
Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localizationAndré Steven, Sandra Leisz, Katharina Sychra, et al.
Molecular Cancer|March 6, 2025
Harnessing myeloid cells in cancerSu-Yeon Park, Ekaterina Pylaeva, Vikas Bhuria, et al.
Cancer|March 9, 2010
Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanomaDimitrios Mougiakakos, C Christian Johansson, Eric Trocme, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2015
Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor ActivityMaarten A Ligtenberg, Dimitrios Mougiakakos, Madhura Mukhopadhyay, et al.
International Journal of Cancer|October 23, 2009
Expression and prognostic significance of iNOS in uveal melanomaC Christian Johansson, Dimitrios Mougiakakos, Eric Trocme, et al.
Pageof 16